Select Criteria: Super Track = Industry Partners Symposia

Friday, September 11, 2:00 PM - 3:00 PM

    How could treatment practice change with cancer immunotherapy combinations in patients with HCC? Welcome and introductions by Peter Galle Navigating the shifting treatment patterns for HCC by Jian Zhou Understanding the latest efficacy data for unresectable HCC by Peter Galle Discussing safety with cancer immunotherapy combinations by Bruno Sangro Making the correct clinical decisions: what do... Read More
    • Industry Symposium

    Friday, September 11, 4:40 PM - 5:40 PM

      Faculty: Sandrine Faivre, Josep Llovet & Arndt Vogel (chair) Duration Topic Presenter 5 min Welcome and introductions Arndt Vogel 15 min Translating latest clinical trials evidence into treatment decisions Sandrine Faivre 15 min Sequencing of systemic therapy in today’s clinical practice Arndt Vogel 15 min Insights from the tumour microenvironment for the 2021 treatment landscape Josep Llovet 10 min Panel discussion and close All   This is... Read More
      • Industry Symposium

      Friday, September 11, 6:20 PM - 7:20 PM

      Saturday, September 12, 2:00 PM - 3:00 PM

        The evolving HCC treatment landscape: what is the role of LENVIMA® monotherapy in first-line uHCC?...
        • Industry Symposium

        Sunday, September 13, 2:00 PM - 3:00 PM

          Y90: A Step Towards Curative Therapies for HCC Long Term Outcomes of Liver Transplant Following Y90       Dr Talia Baker, Transplant Surgeon, University of Chicago, USA SIRT for Downstaging                                                                     Dr Peter Littler, Interventional Radiologist, Freeman Hospital, UK Positioning SIRT in the Treatment Algorithm                           Dr Julien Edeline, Medical Oncologist, Centre Eugene Marquis, France... Read More
          • Industry Symposium